US EditionPublished • loading... • Updated
New GLP-1 alternative, eloralintide, leads to 20% weight loss in trial - Health Care Today
Summary by healthcaretoday.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
New GLP-1 alternative, eloralintide, leads to 20% weight loss in trial - Health Care Today
GLP-1 medications, such as Ozempic and Wegovy, have skyrocketed in popularity and are used to treat type 2 diabetes and aid in weight loss. However, studies show they do not work for everyone, especially when it comes to weight loss. A new study found that a new type of medication, called eloralintide, which targets a different hormone called amylin, helped people achieve meaningful weight loss. However, not everyone who takes a GLP-1 medicatio…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
